Reduce crushing costs
Better management of chronic conditions will be critical to the future of healthcare delivery, according to Tracey Moorhead.
"Certainly having more people with healthcare coverage is going to help keep costs down in one regard, but better management of chronic conditions and prevention of chronic conditions will be crucial to the future of healthcare delivery," Moorhead says. "There are a number of things that are coming together to do that. One is better reimbursement for those types of services. Another is expansion of the healthcare team beyond just the physician."
DMAA advances the emerging population-health-management (PHM) model, which expands on the traditional practice of disease management, reaching out to a broader range of individuals and intervening earlier to prevent or reduce disease-and the associated profit-crushing costs. Delivered through a variety of outreach techniques across the whole spectrum of care, PHM combines prevention and management to create a recipe for bending the cost curve, she says.
DMAA, based in Washington, D.C., is the industry's resource center of population health management strategies. Its 200 members include health plans, employers, government programs and agencies, carve-outs, providers and researchers. Conducting its own original research, DMAA collaborates on industry standards and makes national policy recommendations.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Positive Pipeline Updates for Friedreich’s Ataxia
October 24th 2024After experiencing setbacks, PTC reported positive results for vatiquinone, its selective inhibitor of 15-Lipoxygenase (15-LO) enzyme, regulator of the energetic and oxidative stress pathways that are disrupted in Friedreich ataxia
Read More
